Notes to the Accounts (continued)
18. Negative goodwill
Group 2011 £000
At 1 April 2010 Amortisation
At 31 March 2011 19. Debtors
Group 2011 £000
Trade debtors Amounts due from Group undertakings Taxation recoverable Other debtors Prepayments Accrued legacy income Accrued other income
5,359 –
10,343 1,748
10,946 80,710 9,257
118,363
Group 2010 £000
5,780 –
10,371 21,891 11,901 81,335 9,103
140,381
Charity 2011 £000
4,394 4,935
10,418 1,480 9,982
80,710 3,314
115,232
Charity 2010 £000
4,194 4,191
10,472 21,533 10,620 81,335 3,761
136,106
Other debtors include balances due after more than one year of £0.9 million (2010: £1.1 million). A small proportion of accrued legacy income may be received after more than one year, but a figure has not been calculated due to the inherent uncertainty in the timing of legacy income receipt.
Other debtors at 31 March 2010 included £19.3 million proceeds of sale of Charity freehold properties. This was received in full in 2011.
The Charity has made a loan to its trading subsidiary company Cancer Research Technology Ltd (CRT) amounting to £1 million. The loan is secured on the assets of CRT, excluding intellectual property, and attracts interest at base rate plus 1%. The amount outstanding is repayable in full on 31 March 2015 or on 13 calendar months’ notice from the Charity.
20a) Creditors: amounts falling due within one year
Group 2011 £000
Research grants payable Life chairs and fellowships Trade creditors Amounts due to Group undertakings Tax and social security creditors Other creditors Accruals Deferred income
127,083 786
9,199 –
4,415 2,114
27,715 19,816
191,128
Group 2010 £000
144,324 1,273
11,535 –
4,068 2,473
23,353 15,768
202,794
Charity 2011 £000
127,083 481
6,625
20,142 4,312 1,974
19,243 15,082
194,942
Charity 2010 £000
144,324 1,134 7,656
24,588 3,956 2,462
15,157 10,297
209,574
(5,572) 778
(4,794)
Group 2010 £000
(6,349) 777
(5,572)
46 / Annual Report and Accounts / Notes to the Accounts
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64